MPP is an international public health foundation established in 2010 by Unitaid. MPP was created to address a fundamental barrier to access to medicines in LMICs: the lack of timely, affordable access to patent-protected health technologies. MPP’s model is distinctive in that it is based on negotiating voluntary, public-health-oriented licences with patent holders, enabling multiple manufacturers to produce high-quality, low-cost versions of essential medicines and health technologies. These licences are often complemented by technology transfer and support for manufacturing scale-up, thereby strengthening regional and local production capacity.
Operating as a neutral and trusted intermediary, MPP works in close partnership with governments, United Nations agencies, civil society organisations, research institutes, and both originator and generic pharmaceutical companies. This partnership-driven model has positioned MPP as a central actor in the global access-to-medicines ecosystem and a recognised leader in innovative, collaborative approaches to intellectual property management for public health.
In collaboration with Ganci Partners, The Medicines Patent Pool is recruiting its future Executive Director.
Location: Geneva, Switzerland Travel: up to 30%
MPP is seeking an Executive Direction that will steer the implementation of MPP’s strategy They will lead high-level engagement and negotiations with a wide range of stakeholders, including governments, pharmaceutical companies, manufacturers, donors, multilateral institutions, and civil society organisation, while reporting to the Governance Board. The role requires balancing public health objectives with commercial realities and navigating complex political, ethical, and reputational considerations.
Responsibilities
How to Apply – Please send your CV and a motivation statement outlining your interest, achievements, and qualifications to talent@gancipartners.ch – with the reference AHMB001 – Deadline for applications: February 16, 2026.
For more information about MPP, visit: www.medicinespatentpool.org
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.